The top ten things that must be known about end of life therapy in patients with advanced cancer
Crossref DOI link: https://doi.org/10.1007/s12254-020-00572-6
Published Online: 2020-01-16
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kreye, Gudrun http://orcid.org/0000-0003-0674-7079
Heidecker, Bettina
Masel, Eva K.
Text and Data Mining valid from 2020-01-16
Version of Record valid from 2020-01-16
Article History
Received: 14 November 2019
Accepted: 3 January 2020
First Online: 16 January 2020
Conflict of interest
: G. Kreye, B. Heidecker, and E.K. Masel declare that they have no competing interests.